News

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows
Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...
Drugmaker Novo Nordisk warns consumers about counterfeit versions of Ozempic in US
Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...
Fake Ozempic drugs found in US drug supply, FDA warns
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...
Health News Florida3d
The FDA warns patients about counterfeit Ozempic that may be in circulation
The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...
Daily Voice5d
FDA Seizes Counterfeit Ozempic, Novo Nordisk Issues Warning
The maker of Ozempic and federal regulators are sending out warnings about counterfeit versions of the anti-diabetic drug ...
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
FDA warns fake Ozempic may not be safe
The FDA and Novo Nordisk are warning of counterfeit Ozempic® (semaglutide) which could pose a safety risk. The FDA and ...
Futurism on MSN1d
Novo Nordisk Is Getting Absolutely Destroyed
Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.